<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wellington D</submitter><funding>Medical Research Council</funding><pagination>e20076</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10570596</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(10)</volume><pubmed_abstract>Mutations within viral epitopes can result in escape from T cells, but the contribution of mutations in flanking regions of epitopes in SARS-CoV-2 has not been investigated. Focusing on two SARS-CoV-2 nucleoprotein CD8&lt;sup>+&lt;/sup> epitopes, we investigated the contribution of these flanking mutations to proteasomal processing and T cell activation. We found decreased NP&lt;sub>9-17&lt;/sub>-B*27:05 CD8&lt;sup>+&lt;/sup> T cell responses to the NP-Q7K mutation, likely due to a lack of efficient epitope production by the proteasome, suggesting immune escape caused by this mutation. In contrast, NP-P6L and NP-D103 N/Y mutations flanking the NP&lt;sub>9-17&lt;/sub>-B*27:05 and NP&lt;sub>105-113&lt;/sub>-B*07:02 epitopes, respectively, increased CD8&lt;sup>+&lt;/sup> T cell responses associated with enhanced epitope product</pubmed_abstract><journal>Heliyon</journal><pubmed_title>SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cell responses.</pubmed_title><pmcid>PMC10570596</pmcid><funding_grant_id>G0501068</funding_grant_id><pubmed_authors>Peng Y</pubmed_authors><pubmed_authors>Dong T</pubmed_authors><pubmed_authors>Fischer R</pubmed_authors><pubmed_authors>Davis S</pubmed_authors><pubmed_authors>Heilig R</pubmed_authors><pubmed_authors>Kessler BM</pubmed_authors><pubmed_authors>Yao X</pubmed_authors><pubmed_authors>Yin Z</pubmed_authors><pubmed_authors>Dong D</pubmed_authors><pubmed_authors>Wellington D</pubmed_authors><pubmed_authors>Antoun E</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>Hublitz P</pubmed_authors><pubmed_authors>Beveridge R</pubmed_authors><pubmed_authors>Felce SL</pubmed_authors><pubmed_authors>Liu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T cell responses.</name><description>Mutations within viral epitopes can result in escape from T cells, but the contribution of mutations in flanking regions of epitopes in SARS-CoV-2 has not been investigated. Focusing on two SARS-CoV-2 nucleoprotein CD8&lt;sup>+&lt;/sup> epitopes, we investigated the contribution of these flanking mutations to proteasomal processing and T cell activation. We found decreased NP&lt;sub>9-17&lt;/sub>-B*27:05 CD8&lt;sup>+&lt;/sup> T cell responses to the NP-Q7K mutation, likely due to a lack of efficient epitope production by the proteasome, suggesting immune escape caused by this mutation. In contrast, NP-P6L and NP-D103 N/Y mutations flanking the NP&lt;sub>9-17&lt;/sub>-B*27:05 and NP&lt;sub>105-113&lt;/sub>-B*07:02 epitopes, respectively, increased CD8&lt;sup>+&lt;/sup> T cell responses associated with enhanced epitope product</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-29T06:11:54.366Z</modification><creation>2025-04-06T01:59:41.242Z</creation></dates><accession>S-EPMC10570596</accession><cross_references><pubmed>37842619</pubmed><doi>10.1016/j.heliyon.2023.e20076</doi></cross_references></HashMap>